Cargando…
Risk selection into supplemental private health insurance in China
BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mat...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918563/ https://www.ncbi.nlm.nih.gov/pubmed/31848759 http://dx.doi.org/10.1186/s13561-019-0252-8 |
_version_ | 1783480614345768960 |
---|---|
author | Jiang, Yawen Ni, Weiyi |
author_facet | Jiang, Yawen Ni, Weiyi |
author_sort | Jiang, Yawen |
collection | PubMed |
description | BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mature. However, evidence on this important aspect of the supplemental PHI market in China is still absent in the literature. The private insurers in China were not prohibited from discrimination against pre-existing conditions and did not guarantee ongoing enrolment. Therefore, the direction and degree of risk selection could not be inferred using the evidence from the other countries. To provide evidence on risk selection into supplemental PHI in China, we conducted a cross-sectional analysis using data from the 2015 wave of China Health and Retirement Longitudinal Study (CHARLS). RESULTS: Using probit models, we found that individuals having better self-reported general health were more likely to enrol in PHI in China, suggesting advantageous selection. This result was confirmed by an alternative analysis using an instrumental variable. We also adjusted the realized occurrence of hospitalization by excluding potential moral hazard effect and showed that the adjusted hospitalization risk was negatively associated with PHI enrolment, which also indicated advantageous selection. CONCLUSIONS: The findings suggested potential over-insurance of healthier individuals or under-insurance of less healthy individuals. The regulation of the PHI market in China should aim to address the inefficiency. The current study could also contribute to the information base for policymakers in countries where the PHI markets similarly lack strong regulation. |
format | Online Article Text |
id | pubmed-6918563 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-69185632019-12-30 Risk selection into supplemental private health insurance in China Jiang, Yawen Ni, Weiyi Health Econ Rev Research BACKGROUND: Information on risk selection is important for the regulation and development of supplemental private health insurance (PHI). The research on risk selection into supplemental PHI has been documented in several developed countries where the regulation of the PHI markets was relatively mature. However, evidence on this important aspect of the supplemental PHI market in China is still absent in the literature. The private insurers in China were not prohibited from discrimination against pre-existing conditions and did not guarantee ongoing enrolment. Therefore, the direction and degree of risk selection could not be inferred using the evidence from the other countries. To provide evidence on risk selection into supplemental PHI in China, we conducted a cross-sectional analysis using data from the 2015 wave of China Health and Retirement Longitudinal Study (CHARLS). RESULTS: Using probit models, we found that individuals having better self-reported general health were more likely to enrol in PHI in China, suggesting advantageous selection. This result was confirmed by an alternative analysis using an instrumental variable. We also adjusted the realized occurrence of hospitalization by excluding potential moral hazard effect and showed that the adjusted hospitalization risk was negatively associated with PHI enrolment, which also indicated advantageous selection. CONCLUSIONS: The findings suggested potential over-insurance of healthier individuals or under-insurance of less healthy individuals. The regulation of the PHI market in China should aim to address the inefficiency. The current study could also contribute to the information base for policymakers in countries where the PHI markets similarly lack strong regulation. Springer Berlin Heidelberg 2019-12-17 /pmc/articles/PMC6918563/ /pubmed/31848759 http://dx.doi.org/10.1186/s13561-019-0252-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Jiang, Yawen Ni, Weiyi Risk selection into supplemental private health insurance in China |
title | Risk selection into supplemental private health insurance in China |
title_full | Risk selection into supplemental private health insurance in China |
title_fullStr | Risk selection into supplemental private health insurance in China |
title_full_unstemmed | Risk selection into supplemental private health insurance in China |
title_short | Risk selection into supplemental private health insurance in China |
title_sort | risk selection into supplemental private health insurance in china |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918563/ https://www.ncbi.nlm.nih.gov/pubmed/31848759 http://dx.doi.org/10.1186/s13561-019-0252-8 |
work_keys_str_mv | AT jiangyawen riskselectionintosupplementalprivatehealthinsuranceinchina AT niweiyi riskselectionintosupplementalprivatehealthinsuranceinchina |